Similar articles

• Patent ductus arteriosus: experimental aspects.

  Mott JC. Mott JC. Arch Dis Child. 1980 Feb;55(2):99-105. doi: 10.1136/adc.55.2.99. Arch Dis Child. 1980. PMID: 6769398 Free PMC article. Review. No abstract available.
• Plasma-prostaglandins in pre-term neonates before and after treatment for patient ductus arteriosus.

  Lucas A, Mitchell MD. Lucas A, et al. Lancet. 1978 Jul 15;2(8081):130-2. doi: 10.1016/s0140-6736(78)91510-6. Lancet. 1978. PMID: 78327
• Plasma prostaglandin E2 and F2 alpha in preterm infants: association with respiratory distress syndrome and patent ductus arteriosus.

  Kopelman AE, Dombroski D, Engelke SC, Louis TM. Kopelman AE, et al. Prostaglandins Leukot Med. 1983 Apr;10(4):423-31. doi: 10.1016/0262-1746(83)90054-9. Prostaglandins Leukot Med. 1983. PMID: 6574525
• Prostanoids in blood for neonatal transfusion.

  Mitchell MD, Brunt JD, Wilkinson AR, Turnbull AC. Mitchell MD, et al. Lancet. 1978 Dec 23-30;2(8104-5):1382-3. doi: 10.1016/s0140-6736(78)92020-2. Lancet. 1978. PMID: 82882 No abstract available.
• Patent ductus arteriosus. Clinical relevance of prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment.

  Hammerman C. Hammerman C. Clin Perinatol. 1995 Jun;22(2):457-79. Clin Perinatol. 1995. PMID: 7671547 Review.